Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03379467 |
|
Recruitment Status :
Completed
First Posted : December 20, 2017
Last Update Posted : December 21, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies before their fifth birthday. In part, this is due to the low coverage rate of routine childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential that an immunization intervention be developed that is suitable for its socioeconomic setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very low. Moreover the use of SMS in the country has broadened beyond the conventional use of peer-peer chat to include social networking, SMS banking, delivery tracking, advertising, business, disaster management, and identity verification. This study will utilise this prevalence of mobile phones to assess whether simple and interactive sms reminders can serve to increase childhood immunization coverage and timeliness.
The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers at Korangi. The pilot will determine whether automated text messages produce increased immunization coverage in the reminder groups compared to the control group. 656 participants will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results of proposed pilot will provide the basis for a large scale-up study in urban and rural settings in Pakistan.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Immunization; Infection SMS | Other: SMS Reminder Other: Interactive Reminder | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 655 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | This is an individually randomized, three-arm parallel group design randomized control trial with equal allocation in the two treatment groups and control group. The parents of infants in SMS and interactive reminder groups will receive 3-5 reminders for scheduled follow-up immunization visits. The difference in between SMS and interactive reminders is that parents in SMS reminders are not asked to respond back to SMS reminders. The infants in control group will carry out routine follow-ups without any added intervention. |
| Masking: | None (Open Label) |
| Masking Description: | The allocation sequence will be concealed from the study staff responsible for screening and enrolling participants in serially numbered, opaque, sealed envelopes. |
| Primary Purpose: | Health Services Research |
| Official Title: | Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage: A Randomized Controlled Trial |
| Actual Study Start Date : | May 23, 2011 |
| Actual Primary Completion Date : | March 8, 2014 |
| Actual Study Completion Date : | March 8, 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: SMS Reminder
Single SMS at each of the following times:
|
Other: SMS Reminder
A text message sent as a reminder for immunization on the registered phone number |
|
Experimental: Interactive Reminder
Single SMS at each of the following times:
|
Other: Interactive Reminder
A text message sent as a reminder for immunization on the registered phone number which requires the receiver to respond back |
|
No Intervention: Control
Subjects in this arm will not receive any intervention
|
- Measles - 2 Completion [ Time Frame: When the participants reach 2 years of age ]The primary outcome for the study is the proportion of infants completing measles 2 vaccine on schedule.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 6 Weeks to 12 Weeks (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Child presenting for pentavalent 1- vaccine
- Caregivers who owned a cellphone or had access to one
- Caregivers permanently residing in Korangi Town, Karachi
Exclusion Criteria:
- Child presenting for a vaccine other than pentavalent -1
- Caregivers not having access to a cell phone
- Caregivers residing outside of Korangi or planning to move from the catchment area
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03379467
| Principal Investigator: | Subhash Chandir, Phd | Interactive Research and Development (IRD) |
| Responsible Party: | Subhash Chandir, Primary Investigator, Interactive Research and Development |
| ClinicalTrials.gov Identifier: | NCT03379467 |
| Other Study ID Numbers: |
IRD_IRB_2011_05_005 |
| First Posted: | December 20, 2017 Key Record Dates |
| Last Update Posted: | December 21, 2017 |
| Last Verified: | December 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
SMS Reminder Two-way Reminder |

